Stockreport

Atossa Therapeutics shares rise after FDA grants orphan drug designation for soft tissue sarcoma [Seeking Alpha]

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com
PDF designation, offering potential support for the development of this rare cancer therapy. Atossa Therapeutics' ( ATOS ) shares rose over 13% to in premarket trading. [Read more]